Verfahren zur Behandlung von Vitiligo
EP4725547
15. April 2026
Anmelder: Pfizer Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4725547
- Anmeldetag
- 28. März 2022
- Veröffentlichung
- 15. April 2026
- Rechtsraum
- EP
- IPC
- A61K31/519, A61P17/00A61P17/00
Abstract
Method for treating vitiligo, including active and stable non-segmental vitiligo, using compounds and analogues which inhibit certain kinases including Janus Kinase (JAK), said method comprising the step of administering to the subject in need thereof 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one, or a pharmaceutically acceptable salt thereof.
Anmelder
- Firma
- Pfizer Inc.
- Land
- 🇺🇸 USA